Krsnaa Diagnostics, a company in the Healthcare Service Provider industry, reported revenue of ₹240 crore and net profit of ₹25 crore for the September 2026 quarter.
Krsnaa Diagnostics (NSE: KRSNAA) closed at ₹519.05 on 20 Nov 2026, down 36.5% over the past year. Its market capitalisation is ₹1,684 crore and it trades at 16.7 times earnings.
Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.